Antony A. Fuleihan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antony A. Fuleihan has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Nicholas Theodore
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA
3 shared publications - A. Daniel Davidar
Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
2 shared publications Arjun K. Menta
Johns Hopkins University School of Medicine, Baltimore, Maryland
2 shared publications- Arjun Kumar Menta
HEPIUS Innovation Laboratory, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
2 shared publications Patrick Kramer
Department of Neurosurgery, Johns Hopkins University School of Medicine, 1800 Orleans St., Baltimore, MD 21287, USA
2 shared publicationsAdam Metwalli
Department of Urology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
1 shared publication
Latest Publications
- 1 July 2026
- Published by Wolters Kluwer Health in Urology Practice
- Vol. 13 (4) , 358-366
Urologic Device Innovation and Trends: An Analysis of Food and Drug Administration Approvals From 1990 to 2023
Urology has historically led surgical innovation with the early adoption of endoscopy, minimally invasive surgery, and neurostimulation devices. However, the current trajectory of innovation across urologic subspecialties remains undefined. To characterize trends in U.S. Food and Drug Administration (FDA) device approvals in urology from 1990 to 2023 and assess regulatory, market, and subspecialty factors associated with device development activity. FDA databases were queried for all devices approved through the Gastroenterology-Urology Device Panel between 1990 and 2023. Devices were categorized by subspecialty, regulatory pathway, device class, and company experience. Descriptive statistics and comparative analyses assessed approval trends, processing times, and market entry dynamics. Of 7,860 devices approved by the Gastroenterology-Urology Panel, 4,300 (54.7%) were urologic. Device approvals peaked in 1994 and then declined 76% between 1994 to 2023. Endourology accounted for 50.6% of devices, but experienced a 60.7% decline in growth. Urogynecology and reconstructive pelvic surgery (URPS) and neurourology demonstrated significant growth (833.3% and 650.0%, respectively), albeit from a low baseline. Most devices were Class II (94.0%) and approved via the 510(k) pathway (98.7%). Approval times varied by device class (p < 0.001) and were shorter for companies with prior regulatory experience (p < 0.001). Urologic device regulatory approvals have declined since the 1990s in traditionally dominant subspecialties. While growth is emerging in underrepresented areas such as URPS and neurourology, prolonged approval timelines within these subspecialties may impede progress. Regulatory reform and industry support may help revitalize innovation in urologic technology.
- 1 July 2026
- Published by Wolters Kluwer Health in Urology Practice
- Vol. 13 (4) , 358-366
Urologic Device Innovation and Trends: An Analysis of Food and Drug Administration Approvals From 1990 to 2023
Urology has historically led surgical innovation with the early adoption of endoscopy, minimally invasive surgery, and neurostimulation devices. However, the current trajectory of innovation across urologic subspecialties remains undefined. To characterize trends in U.S. Food and Drug Administration (FDA) device approvals in urology from 1990 to 2023 and assess regulatory, market, and subspecialty factors associated with device development activity. FDA databases were queried for all devices approved through the Gastroenterology-Urology Device Panel between 1990 and 2023. Devices were categorized by subspecialty, regulatory pathway, device class, and company experience. Descriptive statistics and comparative analyses assessed approval trends, processing times, and market entry dynamics. Of 7,860 devices approved by the Gastroenterology-Urology Panel, 4,300 (54.7%) were urologic. Device approvals peaked in 1994 and then declined 76% between 1994 to 2023. Endourology accounted for 50.6% of devices, but experienced a 60.7% decline in growth. Urogynecology and reconstructive pelvic surgery (URPS) and neurourology demonstrated significant growth (833.3% and 650.0%, respectively), albeit from a low baseline. Most devices were Class II (94.0%) and approved via the 510(k) pathway (98.7%). Approval times varied by device class (p < 0.001) and were shorter for companies with prior regulatory experience (p < 0.001). Urologic device regulatory approvals have declined since the 1990s in traditionally dominant subspecialties. While growth is emerging in underrepresented areas such as URPS and neurourology, prolonged approval timelines within these subspecialties may impede progress. Regulatory reform and industry support may help revitalize innovation in urologic technology.
- Open Access
- 30 January 2026
- Published by Elsevier in Journal of Surgical Education
- Vol. 83 (4) , 103865
Factors Influencing Match Success in Integrated Vascular Surgery Residency Programs From 2019 to 2023
- 30 January 2026
- Published by Elsevier in Journal of Surgical Education
- Vol. 83 (4) , 103865
Open AccessFactors Influencing Match Success in Integrated Vascular Surgery Residency Programs From 2019 to 2023
- 25 August 2025
- Published by Elsevier in The Spine Journal
- Vol. 26 (1) , 203-204
Letter to the Editor regarding “The hidden cost of robotic spine surgery: real-world adverse events cause 58-minute delays and undermine economic viability” by Schneider et al
- 25 August 2025
- Published by Elsevier in The Spine Journal
- Vol. 26 (1) , 203-204
Letter to the Editor regarding “The hidden cost of robotic spine surgery: real-world adverse events cause 58-minute delays and undermine economic viability” by Schneider et al
- Open Access
- 13 March 2025
- Published by Elsevier in World Neurosurgery
- Vol. 196, 123797
Are Mildly Disabled Patients Appropriate for Spine Bundles? An Application of the Operative Value Index
- 13 March 2025
- Published by Elsevier in World Neurosurgery
- Vol. 196, 123797
Open AccessAre Mildly Disabled Patients Appropriate for Spine Bundles? An Application of the Operative Value Index
- 14 February 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 96 (3S) , S94-S102
Beyond Pedicle Screw Placement: Future Minimally Invasive Applications of Robotics in Spine Surgery
Advancements in spine surgery have dramatically enhanced minimally invasive techniques, prominently through integrating robotic systems. Although pedicle screw placement remains the most widespread application of this technology, new developments are emerging to create innovative future avenues for these tools. This review explores the promising applications of robotic technology in minimally invasive spinal procedures, ranging from assistance with laminectomies and vertebroplasty to pain management and treatment of spinal tumors. We also discuss the potential for integrating artificial intelligence and augmented reality with robotic systems. If the current trajectory of research and innovation continues, there is promise in creating fully autonomous robotic systems that can revolutionize spine surgery by processing, planning, and performing procedures without heavy reliance on the surgeon.
- 14 February 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 96 (3S) , S94-S102
Beyond Pedicle Screw Placement: Future Minimally Invasive Applications of Robotics in Spine Surgery
Advancements in spine surgery have dramatically enhanced minimally invasive techniques, prominently through integrating robotic systems. Although pedicle screw placement remains the most widespread application of this technology, new developments are emerging to create innovative future avenues for these tools. This review explores the promising applications of robotic technology in minimally invasive spinal procedures, ranging from assistance with laminectomies and vertebroplasty to pain management and treatment of spinal tumors. We also discuss the potential for integrating artificial intelligence and augmented reality with robotic systems. If the current trajectory of research and innovation continues, there is promise in creating fully autonomous robotic systems that can revolutionize spine surgery by processing, planning, and performing procedures without heavy reliance on the surgeon.
- Open Access
- 12 October 2024
- Published by OAE Publishing Inc. in Artificial Intelligence Surgery
- Vol. 4 (4) , 288-95
Navigating artificial intelligence in spine surgery: implementation and optimization across the care continuum
The field of spine surgery has long been characterized by innovations and technological advancements. The integration of artificial intelligence (AI) into spine surgery represents one of the latest technical developments in the field. The ability of AI to rapidly analyze datasets improves decision making, risk assessment, intraoperative precision, and postoperative management, all of which contribute to increasing personalized spine care and improving outcomes. However, the successful implementation of AI faces regulatory and privacy challenges that must be addressed before its full potential can be realized. Here, we provide a detailed analysis of the current applications and future prospects of AI in spine surgery, highlighting both the opportunities and challenges in this evolving field.
- 12 October 2024
- Published by OAE Publishing Inc. in Artificial Intelligence Surgery
- Vol. 4 (4) , 288-95
Open AccessNavigating artificial intelligence in spine surgery: implementation and optimization across the care continuum
The field of spine surgery has long been characterized by innovations and technological advancements. The integration of artificial intelligence (AI) into spine surgery represents one of the latest technical developments in the field. The ability of AI to rapidly analyze datasets improves decision making, risk assessment, intraoperative precision, and postoperative management, all of which contribute to increasing personalized spine care and improving outcomes. However, the successful implementation of AI faces regulatory and privacy challenges that must be addressed before its full potential can be realized. Here, we provide a detailed analysis of the current applications and future prospects of AI in spine surgery, highlighting both the opportunities and challenges in this evolving field.
- 15 April 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Pulse
- Vol. 15 (1) , 9-14
Health Care Innovation for Low-Resource Settings: The Value of Local Immersion and Partnership
Health Care Innovation is the creation, development, and translation of new and better solutions to health care challenges. At its core, this endeavor does not require extending the frontiers of science or the creation of new fundamental technologies. Rather, it is primarily focused on the use of existing science and established technologies in the design of new solutions to problems in health care. Successfully innovating for low- and middle-income countries (LMICs) requires a needs and stakeholder-driven approach to enable development and adoption of available, accessible, and acceptable solutions tailored to the specific need and context of care.
- 15 April 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Pulse
- Vol. 15 (1) , 9-14
Health Care Innovation for Low-Resource Settings: The Value of Local Immersion and Partnership
Health Care Innovation is the creation, development, and translation of new and better solutions to health care challenges. At its core, this endeavor does not require extending the frontiers of science or the creation of new fundamental technologies. Rather, it is primarily focused on the use of existing science and established technologies in the design of new solutions to problems in health care. Successfully innovating for low- and middle-income countries (LMICs) requires a needs and stakeholder-driven approach to enable development and adoption of available, accessible, and acceptable solutions tailored to the specific need and context of care.